Interestingly enough, two substrates of KLK8 (ephrin receptor B2 and FKBP prolyl isomerase 5) were significantly elevated in early AD stages in the same study, although their levels diminished as KLK8’s increased. This evidence concerns the gene FKBP5 and Alzheimer disease.